i
Loading Page
loading, please wait

Select Year:

Home > NY Providers
provider's profile picture

Dr. Scott T. Tagawa, MD, MS, FACP

Accepting New Patients
(Scott T. Tagawa, M.D., MS, FACP, FASCO)

(No ratings)

Specializes in: Medical Oncology, Physician and Hematology (Blood Disorders)
University of Southern California (USC), Keck School of Medicine (1998)
Professional interests include: thrombosis (blood clots), kidney cancer, genitourinary cancer, and more.
525 East 68th Street Starr 900
New York, NY 10065

Dr. Scott T. Tagawa, MD, MS, FACP is a medical oncologist in New York, NY specializing in medical oncology, physician and hematology (blood disorders). He graduated from University of Southern California (USC), Keck School of Medicine in 1998 and has 28 years of experience. Dr. Scott T. Tagawa, MD, MS, FACP is affiliated with NewYork-Presbyterian, Weill Cornell Medicine and Multidisciplinary Prostate Cancer Clinic.

View Doctor's Full Profile (646) 962-2072

Office Locations

525 East 68th Street Starr 900
New York, NY 10065
open_in_new
520 East 70th Street Starr Pavilion, 3rd Floor
New York, NY 10021
open_in_new
525 E 68th Street #900 New
York, NY 10065
open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2012 were hormone therapy, hospital care, inpatient care and preventive care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 847
hormone therapy 205
hospital care 172
inpatient care 172
preventive care 11
vaccines 11

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2013 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 920
hormone therapy 236
hospital care 58
inpatient care 58

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 197
Female 48
Ethnicity
Non-Hispanic White 180
Black 29
Hispanic 22
Asian 0
Other 0
Native American 0
Age
From 65 to 74 120
From 75 to 84 83
85 and over 26
Less than 65 16

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2013

Hypertension 68
High Cholesterol 53
Stroke 5
Ischemic Heart Disease 44
Depression 19
Chronic Kidney Disease 39
Asthma 6
Osteoperosis 8
Atrial Fibrilation 7
Heart Failure 22
Chronic Obstructive Pulmonary Disease 9
Diabetes 33
Dementia 10
Cancer 73

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2014 were hormone therapy, hospital care, inpatient care and preventive care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 963
hormone therapy 238
hospital care 148
inpatient care 148
preventive care 13
vaccines 13

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 223
Female 75
Ethnicity
Non-Hispanic White 213
Black 24
Hispanic 33
Asian 0
Other 0
Native American 0
Age
From 65 to 74 138
From 75 to 84 105
85 and over 33
Less than 65 22

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2014

Hypertension 73
High Cholesterol 59
Stroke 5
Ischemic Heart Disease 51
Depression 24
Chronic Kidney Disease 46
Asthma 8
Osteoperosis 12
Atrial Fibrilation 12
Heart Failure 24
Chronic Obstructive Pulmonary Disease 10
Diabetes 34
Dementia 9
Cancer 73

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2015 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 966
hormone therapy 274
hospital care 140
inpatient care 140

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 478
Female 102
Ethnicity
Non-Hispanic White 434
Black 56
Hispanic 50
Asian 0
Other 0
Native American 0
Age
From 65 to 74 238
From 75 to 84 228
85 and over 74
Less than 65 40

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2015

Hypertension 68
High Cholesterol 54
Stroke 5
Ischemic Heart Disease 51
Depression 22
Chronic Kidney Disease 41
Asthma 9
Osteoperosis 13
Atrial Fibrilation 12
Heart Failure 27
Chronic Obstructive Pulmonary Disease 10
Diabetes 29
Dementia 9
Cancer 75

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2016 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1204
hormone therapy 377
hospital care 127
inpatient care 127

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 263
Female 49
Ethnicity
Non-Hispanic White 250
Black 24
Hispanic 16
Asian 0
Other 0
Native American 0
Age
From 65 to 74 131
From 75 to 84 124
85 and over 40
Less than 65 17

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2016

Hypertension 63
High Cholesterol 53
Stroke 6
Ischemic Heart Disease 44
Depression 21
Chronic Kidney Disease 45
Asthma 13
Osteoperosis 8
Atrial Fibrilation 12
Heart Failure 27
Chronic Obstructive Pulmonary Disease 10
Diabetes 32
Dementia 13
Cancer 75

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2017 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1121
hormone therapy 358
hospital care 108
inpatient care 108

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 253
Female 44
Ethnicity
Non-Hispanic White 232
Black 28
Hispanic 16
Asian 0
Other 0
Native American 0
Age
From 65 to 74 120
From 75 to 84 119
85 and over 42
Less than 65 16

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2017

Hypertension 67
High Cholesterol 49
Stroke 6
Ischemic Heart Disease 45
Depression 26
Chronic Kidney Disease 43
Asthma 7
Osteoperosis 12
Atrial Fibrilation 12
Heart Failure 20
Chronic Obstructive Pulmonary Disease 11
Diabetes 30
Dementia 12
Cancer 75

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2018 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1108
hormone therapy 352
hospital care 112
inpatient care 112

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 283
Female 47
Ethnicity
Non-Hispanic White 262
Black 28
Hispanic 21
Asian 0
Other 0
Native American 0
Age
From 65 to 74 142
From 75 to 84 140
85 and over 36
Less than 65 12

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2018

Hypertension 71
High Cholesterol 59
Stroke 6
Ischemic Heart Disease 45
Depression 25
Chronic Kidney Disease 46
Asthma 8
Osteoperosis 14
Atrial Fibrilation 14
Heart Failure 20
Chronic Obstructive Pulmonary Disease 11
Diabetes 27
Dementia 12
Cancer 75

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2019 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1063
hormone therapy 366
hospital care 119
inpatient care 119

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 279
Female 40
Ethnicity
Non-Hispanic White 238
Black 27
Hispanic 20
Asian 12
Other 22
Native American 0
Age
From 65 to 74 146
From 75 to 84 109
85 and over 50
Less than 65 14

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2019

Hypertension 69
High Cholesterol 57
Stroke 7
Ischemic Heart Disease 47
Depression 0
Chronic Kidney Disease 49
Asthma 4
Osteoperosis 16
Atrial Fibrilation 13
Heart Failure 20
Chronic Obstructive Pulmonary Disease 13
Diabetes 32
Dementia 13
Cancer 75

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2020 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1014
hormone therapy 162
hospital care 45
inpatient care 45

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 278
Female 13
Ethnicity
Non-Hispanic White 232
Black 14
Hispanic 11
Asian 11
Other 23
Native American 0
Age
From 65 to 74 127
From 75 to 84 118
85 and over 35
Less than 65 11

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2020

Hypertension 67
High Cholesterol 58
Stroke 4
Ischemic Heart Disease 46
Depression 21
Chronic Kidney Disease 47
Asthma 5
Osteoperosis 13
Atrial Fibrilation 13
Heart Failure 20
Chronic Obstructive Pulmonary Disease 8
Diabetes 27
Dementia 10
Cancer 75

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2021 were hormone therapy, hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1075
hormone therapy 210
hospital care 45
inpatient care 45

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 263
Female 17
Ethnicity
Non-Hispanic White 225
Black 19
Hispanic 0
Asian 14
Other 0
Native American 0
Age
From 65 to 74 108
From 75 to 84 112
85 and over 44
Less than 65 16

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2021

Hypertension 67
High Cholesterol 57
Stroke 7
Ischemic Heart Disease 45
Depression 22
Chronic Kidney Disease 44
Asthma 6
Osteoperosis 18
Atrial Fibrilation 11
Heart Failure 20
Chronic Obstructive Pulmonary Disease 8
Diabetes 25
Dementia 10
Cancer 75

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2022 were hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 1028
hospital care 26
inpatient care 26

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 213
Female 14
Ethnicity
Non-Hispanic White 180
Black 13
Hispanic 0
Asian 13
Other 0
Native American 0
Age
From 65 to 74 80
From 75 to 84 95
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2022

Hypertension 75
High Cholesterol 70
Stroke 8
Ischemic Heart Disease 35
Depression 23
Chronic Kidney Disease 28
Asthma 8
Osteoperosis 25
Atrial Fibrilation 22
Heart Failure 19
Chronic Obstructive Pulmonary Disease 13
Diabetes 28
Dementia 7
Cancer 75

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY during 2023 were hospital care and inpatient care.

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 935
hospital care 40
inpatient care 40

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 221
Female 12
Ethnicity
Non-Hispanic White 179
Black 19
Hispanic 11
Asian 13
Other 11
Native American 0
Age
From 65 to 74 82
From 75 to 84 103
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2023

Hypertension 75
High Cholesterol 75
Stroke 10
Ischemic Heart Disease 39
Depression 22
Chronic Kidney Disease 30
Asthma 6
Osteoperosis 26
Atrial Fibrilation 24
Heart Failure 18
Chronic Obstructive Pulmonary Disease 12
Diabetes 32
Dementia 7
Cancer 75

Medicare Procedure and Patient Information

2024 Medicare Procedure Volume

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

doctor visit 895

2024 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 220
Female 11
Ethnicity
Non-Hispanic White 176
Black 14
Hispanic 14
Asian 14
Other 13
Native American 0
Age
From 65 to 74 82
From 75 to 84 102
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP in 2024

Hypertension 75
High Cholesterol 75
Stroke 10
Ischemic Heart Disease 40
Depression 22
Chronic Kidney Disease 30
Asthma 8
Osteoperosis 26
Atrial Fibrilation 23
Heart Failure 19
Chronic Obstructive Pulmonary Disease 12
Diabetes 36
Dementia 7
Cancer 75

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2024

Volume of procedures performed by Dr. Scott T. Tagawa, MD, MS, FACP for Medicare patients.

The highest averages for the top procedures that Dr. Scott T. Tagawa, MD, MS, FACP treated as a medical oncologist in New York, NY were hormone therapy, hospital care, inpatient care and preventive care.

doctor visit 1010
hormone therapy 277
hospital care 95
inpatient care 95
preventive care 12
vaccines 12

Average Medicare Patient Data From 2012 - 2024

Information about Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP.

Gender
Male 243
Female 36
Ethnicity
Black / African American 22
Asian / Pacific Islander 5
Non-Hispanic White 215
Native American / Alaskan Native 0
Hispanic 16
Other 5
Age
75 to 84 110
85 and over 29
Less than 65 12
65 to 74 116

Average of Total of Conditions of Medicare patients treated by Dr. Scott T. Tagawa, MD, MS, FACP From 2012 - 2024

The highest averages of the most common conditions of Medicare patients that Dr. Scott T. Tagawa, MD, MS, FACP treated were cancer, hypertension, high cholesterol and ischemic heart disease.

Hypertension 64
High Cholesterol 55
Stroke 6
Ischemic Heart Disease 40
Depression 19
Chronic Kidney Disease 37
Asthma 6
Osteoporosis 14
Heart Failure 19
Chronic Obstructive Pulmonary Disease 9
Diabetes 28
Atrial Fibrillation 13
Cancer 68
Dementia 9

Education & Training

Dr. Scott T. Tagawa, MD, MS, FACP graduated from University of Southern California (USC), Keck School of Medicine in 1998. He completed residency at Los Angeles County+USC Medical Center. He is certified by the Board Certification: medical oncology and has a state license in California.

Medical School: University of Southern California (USC), Keck School of Medicine (1998)

Residency: Los Angeles County+USC Medical Center

Board Certification: Board Certification: medical oncology

Licensed In: California

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Scott T. Tagawa, MD, MS, FACP appears to accept the following insurance providers: GHI, Health Insurance Plan of NY (HIP), EmblemHealth, WellCare, Healthspring, AETNA, Quality Health Management (QHM), UnitedHealthcare, United Healthcare, Oxford Health Plans, CIGNA, Local 1199, Fidelis Care, Molina Healthcare, Healthfirst, Anthem Blue Cross/Blue Shield Healthplus, Aetna - NYP, VNSNY CHOICE, Rockefeller University/Luminare, VNS Health, WorldWide Medical, Amida Care, United Healthcare Community Plan (AmeriChoice), Aetna Medicare, United Healthcare Medicare, Medicare Advantage, GHI CBP, United Healthcare Empire Plan, Affinity Health Plan, Medicare, Medicaid, Aetna PPO, Aetna HMO, Aetna-NYP EPO/POS, Aetna Weill Cornell Employee Managed Care Plan, Oxford Health Plans Liberty, Oxford Health Plans Freedom, VNSNY CHOICE Medicare, Aetna Weill Cornell Employee PPO Plan, Rockefeller University - Trustmark, VNSNY CHOICE HMO and Oxford Health Plans Metro/Core/Charter.

Insurance Accepted by Provider includes:

According to our sources, Dr. Scott T. Tagawa, MD, MS, FACP accepts the following insurance providers:

GHI
Health Insurance Plan of NY (HIP)
EmblemHealth
WellCare
Healthspring
AETNA
Quality Health Management (QHM)
UnitedHealthcare
United Healthcare
Oxford Health Plans
CIGNA
Local 1199
Fidelis Care
Molina Healthcare
Healthfirst
Anthem Blue Cross/Blue Shield Healthplus
Aetna - NYP
VNSNY CHOICE
Rockefeller University/Luminare
VNS Health
WorldWide Medical
Amida Care
United Healthcare Community Plan (AmeriChoice)
Aetna Medicare
United Healthcare Medicare
Medicare Advantage
GHI CBP
United Healthcare Empire Plan
Affinity Health Plan
Medicare
Medicaid
Aetna PPO
Aetna HMO
Aetna-NYP EPO/POS
Aetna Weill Cornell Employee Managed Care Plan
Oxford Health Plans Liberty
Oxford Health Plans Freedom
VNSNY CHOICE Medicare
Aetna Weill Cornell Employee PPO Plan
Rockefeller University - Trustmark
VNSNY CHOICE HMO
Oxford Health Plans Metro/Core/Charter

Ratings & Reviews

Dr. Scott T. Tagawa, MD, MS, FACP does not have any reviews yet, be the first to leave a review of Dr. Scott T. Tagawa, MD, MS, FACP here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Scott T. Tagawa, MD, MS, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Merck Sharp & Dohme LLC $52,961 KEYTRUDA
$7,218
$45,743
GENZYME CORPORATION $51,333 JEVTANA
$50,552 		NO PRODUCT DISCUSSED
$781
Janssen Biotech, Inc. $50,923 Erleada
$32,619 		ZYTIGA
$5,921 		Balversa
$5,275 		AKEEGA
$3,875
$3,234
Pfizer Inc. $37,334 XTANDI
$20,263 		TALZENNA
$9,391 		ORGOVYX
$6,818 		PADCEV
$235
$626
Bayer HealthCare Pharmaceuticals Inc. $29,604 Xofigo
$13,141 		Nubeqa
$6,698 		None
$2,871 		Nexavar
$2,101
$4,794
Other $294,400 XTANDI
$27,443 		ILLUCCIX
$22,405 		XGEVA
$16,065 		Trodelvy
$15,489 		JEVTANA
$14,150 		Other
$198,848
Types of Payments
Consulting Fee $317,165
Travel and Lodging $99,913
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,582
Food and Beverage $23,701
Honoraria $23,070
Other $3,125

Research Payments

Dr. Scott T. Tagawa, MD, MS, FACP has received 553 research payments totaling $13,113,403.

Biography

Scott T. Tagawa, MD, MS, FACP, FASCO, is a Professor of Medicine and Urology at Weill Cornell Medicine, and an Attending Physician at NewYork-Presbyterian – Weill Cornell Medical Center. After earning his BS from Georgetown University, Dr. Tagawa received his Medical Degree at the University of Southern California (USC) School of Medicine. After completing his Internship and Residency training at USC, he became Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. Dr. Tagawa had the opportunity to train with international leaders in Genitourinary (GU) Oncology. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary (GU) Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center, Dr. Tagawa took the lead in developing genitourinary clinical trials. He was recruited to Weill Cornell Medicine (WCM)  in 2007. His research covers clinical and translational investigations in genitourinary tumors and thrombosis (blood clotting) in people with cancer. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He specializes in drug development and theranostics in prostate cancer. Dr. Tagawa also serves as leader of the GU Disease Management Team and co-leader of the Experimental Therapeutics Program of the Meyer Cancer Center. He is the WCM principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a funded member of the Genitourinary Committee. Additionally, he serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple “top doctor” award lists.EDUCATION/TRAINING:Georgetown University, Washington D.C. B.S.; 1993.University of Southern California School of Medicine, Los Angeles, CA. M.D.; 1998.Internship, Internal Medicine. University of Southern California Department of Medicine; June 1998 - June 1999.Residency, Internal Medicine. University of Southern California Department of Medicine; July 1999 - June 2001.Chief Resident, University of Southern California Department of Medicine, Los Angeles, CA.; July 2001 -June 2002.Fellowship, Combined program in Hematology and Oncology. University of Southern California Department of Medicine, Divisions of Hematology and Oncology; July 2002 - June 2005.Chief Fellow, Hematology; 2003-04.Chief Fellow, Oncology; 2004-05.Weill Cornell Graduate School of Medical Sciences, Masters of Science in Clinical Investigation; 2010.

Other Providers in New York, NY